Gianluca Ametrano

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.

Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.

Journal: Future oncology (London, England)

Published: August 27, 2026

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 07, 2026

First Results Comparing MLC Versus IRIS CyberKnife Collimators in Prostate Stereotactic Body Radiation Therapy in an Italian Oncology Institute.

First Results Comparing MLC Versus IRIS CyberKnife Collimators in Prostate Stereotactic Body Radiation Therapy in an Italian Oncology Institute.

Journal: Bioengineering (Basel, Switzerland)

Published: March 16, 2026

Light Quality Modulates the Antioxidant Properties of "Microtom" Fruits: A Pilot Study Testing the Radioprotective Effect on Human Cells.

Light Quality Modulates the Antioxidant Properties of "Microtom" Fruits: A Pilot Study Testing the Radioprotective Effect on Human Cells.

Journal: International journal of molecular sciences

Published: January 15, 2026

Optimizing Left-Sided Breast Cancer Radiotherapy: Strategy-Dependent Trade-Offs Among VMAT and Hybrid Techniques.

Optimizing Left-Sided Breast Cancer Radiotherapy: Strategy-Dependent Trade-Offs Among VMAT and Hybrid Techniques.

Journal: Cancer management and research

Published: December 23, 2025

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Journal: Radiation oncology (London, England)

Published: December 19, 2025

Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer.

Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer.

Journal: La Radiologia medica

Published: February 05, 2025

Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.

Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 27, 2025

Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.

Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.

Journal: Frontiers in oncology

Published: July 31, 2023

Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.

Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.

Journal: Cancers

Published: May 19, 2022

SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study.

SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study.

Journal: Life (Basel, Switzerland)

Published: March 31, 2022

Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study.

Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study.

Journal: Cancers

Published: June 22, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026